February 20, 2013
Teva Pharmaceuticals USA Inc. has agreed to a settlement with Gilead Sciences Inc. to end a patent infringement dispute over its planned generic version of antiviral treatment Viread, heading off a trial that was set to begin Wednesday in New York federal court, Gilead said Tuesday.
February 07, 2013
A New York federal judge on Wednesday shot down Teva Pharmaceuticals USA Inc.'s bid to switch out its expert witness for its upcoming trial versus Gilead Sciences Inc. over patents for HIV drugs, finding substituting an expert at this stage would be unfair to Gilead.